Atrial Fibrillation Trial, Recruiting (NCT06801392)

Atrial Fibrillation Trial, Recruiting NCT06801392 Sponsor: Charles University, Czech Republic Condition: Atrial Fibrillation

Printed from Voxsanity (voxsanity.com.au) — NCT06801392 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Atrial Fibrillation

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have atrial fibrillation (an irregular heartbeat) that is not the "paroxysmal" type, meaning it does not come and go in short episodes but is more persistent or permanent
Your doctor has recommended a procedure called catheter ablation to treat your atrial fibrillation, in line with current medical guidelines
You are willing to read and sign a consent form agreeing to take part in the study

Who may not be able to join:

You have a blood disorder that can cause your red blood cells to break down on their own (confirm with trial site)
You have moderate to severe chronic kidney disease (stage 3 or worse), meaning your kidneys are not working at full capacity
You have previously had an ablation procedure on the left side of your heart, whether it was done using pulsed-field energy or radiofrequency energy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +420267 161 111

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06801392

Sponsor: Charles University, Czech Republic

Phase: Not Applicable

Status: Recruiting

Condition: Atrial Fibrillation

Trial contact: +420267 161 111

More information: https://clinicaltrials.gov/study/NCT06801392

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have atrial fibrillation (an irregular heartbeat) that is not the "paroxysmal" type, meaning it does not come and go in short episodes but is more persistent or permanent
Your doctor has recommended a procedure called catheter ablation to treat your atrial fibrillation, in line with current medical guidelines
You are willing to read and sign a consent form agreeing to take part in the study

Who may not be able to join:

You have a blood disorder that can cause your red blood cells to break down on their own (confirm with trial site)
You have moderate to severe chronic kidney disease (stage 3 or worse), meaning your kidneys are not working at full capacity
You have previously had an ablation procedure on the left side of your heart, whether it was done using pulsed-field energy or radiofrequency energy

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Charles University, Czech Republic

Registry

ClinicalTrials.gov

Start date

1 January 2025

Est. completion

1 December 2025

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Acute Success of the Left Atrial Posterior Wall Ablation; Acute Success of the Mitral Isthmus Ablation; Serum Creatinine Concentration; Serum Cystatin C Concentration; Serum Neutrophil Gelatinase-Associated Lipocalin Concentration; Red Blood Cell Microparticles; Lactate Dehydrogenase; Platelet Activation Markers; Prothrombosis Fragments; Platelet-Thrombotic Microparticles

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov